企業プロフィール
Statera Biopharma 株価・ニュース・カタリスト
- ティッカー:
- STAB
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.00 USD (0.00%)
終値
最終更新: 2026年8月24日
—
時価総額
株価変動の要因
As of Aug 24, 2026, STAB was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
企業概要
事業概要
Statera Biopharma was an immunotherapy and inflammation-focused biotechnology company that pursued immune modulation in difficult diseases. Its story was rooted in narrow development programs and the challenge of keeping a micro-cap platform alive.
所在地とセクター分類
Statera is headquartered in the United States and listed on NASDAQ. It sits in small-cap immunology biotechnology.
ビジネスモデルの特徴
The company depended on clinical progress, restructuring, and capital preservation. Investors historically watched whether the platform could generate enough data to justify continued development.
バイオ業界での位置付け
Statera occupies a historical micro-cap immunology niche within biotech. The stock was always highly sensitive to financing and program-level updates.
今後のカタリスト
- Statera is a legacy / closeout story, with catalysts limited to any remaining strategic or asset-resolution update. There is no active standalone growth story left.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。